| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.535 | 0.004 | 0.535 | Integrin antagonist | |||
| 0.532 | 0.004 | 0.532 | Cell adhesion inhibitor | 0.493 0.004 CID_102066185 | ||
| 0.541 | 0.024 | 0.756 | Antithrombotic | 0.756 0.005 CID_102066185 | CID_102066185 | |
| 0.459 | 0.005 | 0.459 | Insulin secretagoues | 0.448 0.005 CID_102066185 | ||
| 0.463 | 0.018 | 0.463 | Platelet antagonist | 0.429 0.022 CID_102066185 | ||
| 0.449 | 0.004 | 0.449 | Cell adhesion molecule inhibitor | 0.382 0.005 CID_102066185 | ||
| 0.443 | 0.017 | 0.443 | Psychostimulant | 0.282 0.048 CID_102066185 | ||
| 0.474 | 0.058 | 0.699 | Cyclophilin D inhibitor | 0.699 0.014 CID_102066185 | CID_102066185 | |
| 0.417 | 0.006 | 0.417 | Tyrosine 3 hydroxylase inhibitor | |||
| 0.442 | 0.042 | 0.611 | Cholesterol antagonist | 0.611 0.017 CID_102066185 | CID_102066185 | |
| 0.4 | 0.027 | 0.487 | Interleukin 2 agonist | 0.487 0.01 CID_102066185 | CID_102066185 | |
| 0.378 | 0.013 | 0.396 | Thrombolytic | 0.396 0.012 CID_102066185 | CID_102066185 | |
| 0.371 | 0.007 | 0.371 | Gastrin inhibitor | 0.283 0.046 CID_102066185 | ||
| 0.381 | 0.018 | 0.381 | 5 Hydroxytryptamine uptake stimulant | |||
| 0.359 | 0.003 | 0.359 | Integrin alpha4 antagonist | 0.024 0.019 CID_102066185 | ||
| 0.37 | 0.015 | 0.37 | Diuretic | 0.323 0.019 CID_102066185 | ||
| 0.378 | 0.025 | 0.378 | Sodium/bile acid cotransporter inhibitor | 0.31 0.071 CID_102066185 | ||
| 0.361 | 0.017 | 0.43 | Platelet adhesion inhibitor | 0.43 0.009 CID_102066185 | CID_102066185 | |
| 0.364 | 0.025 | 0.444 | Interleukin agonist | 0.444 0.013 CID_102066185 | CID_102066185 | |
| 0.357 | 0.032 | 0.357 | Insulysin inhibitor | |||
| 0.39 | 0.067 | 0.39 | Calpain 2 inhibitor | |||
| 0.34 | 0.025 | 0.449 | Anesthetic general | 0.449 0.011 CID_102066185 | CID_102066185 | |
| 0.333 | 0.02 | 0.333 | Calpain inhibitor | 0.252 0.063 CID_102066185 | ||
| 0.367 | 0.059 | 0.605 | Immunostimulant | 0.605 0.016 CID_102066185 | CID_102066185 | |
| 0.34 | 0.039 | 0.34 | Superoxide dismutase inhibitor | |||
| 0.367 | 0.074 | 0.367 | Toll-Like receptor agonist | |||
| 0.309 | 0.018 | 0.309 | Thiol protease inhibitor | |||
| 0.304 | 0.014 | 0.304 | Antipruritic | 0.139 0.108 CID_102066185 | ||
| 0.348 | 0.06 | 0.551 | Immunomodulator | 0.551 0.017 CID_102066185 | CID_102066185 | |
| 0.361 | 0.074 | 0.761 | Transcription factor NF kappa B inhibitor | 0.761 0.015 CID_102066185 | CID_102066185 | |
| 0.362 | 0.08 | 0.532 | Immunosuppressant | 0.532 0.025 CID_102066185 | CID_102066185 | |
| 0.338 | 0.062 | 0.434 | Apoptosis antagonist | 0.434 0.03 CID_102066185 | CID_102066185 | |
| 0.283 | 0.012 | 0.283 | Proteasome inhibitor | 0.124 0.062 CID_102066185 | ||
| 0.344 | 0.085 | 0.344 | Toll-Like receptor 7 agonist | |||
| 0.277 | 0.019 | 0.336 | Alpha-N-acetylglucosaminidase inhibitor | 0.336 0.013 CID_102066185 | CID_102066185 | |
| 0.336 | 0.08 | 0.336 | Vasodilator, peripheral | 0.267 0.115 CID_102066185 | ||
| 0.304 | 0.048 | 0.336 | Hypolipemic | 0.336 0.039 CID_102066185 | CID_102066185 | |
| 0.274 | 0.021 | 0.274 | Phospholipase C inhibitor | 0.18 0.061 CID_102066185 | ||
| 0.267 | 0.018 | 0.267 | Neurotensin receptor agonist | |||
| 0.278 | 0.032 | 0.321 | Anticoagulant | 0.321 0.025 CID_102066185 | CID_102066185 | |
| 0.335 | 0.095 | 0.335 | Antiobesity | 0.31 0.109 CID_102066185 | ||
| 0.294 | 0.055 | 0.516 | Hypoglycemic | 0.516 0.014 CID_102066185 | CID_102066185 | |
| 0.238 | 0.006 | 0.238 | Vanilloid 1 agonist | 0.22 0.008 CID_102066185 | ||
| 0.277 | 0.058 | 0.584 | Angiogenesis stimulant | 0.584 0.008 CID_102066185 | CID_102066185 | |
| 0.23 | 0.011 | 0.481 | Cyclooxygenase 3 inhibitor | 0.481 0.003 CID_102066185 | CID_102066185 | |
| 0.234 | 0.015 | 0.234 | Aminopeptidase B inhibitor | |||
| 0.223 | 0.005 | 0.223 | Prolactin inhibitor | |||
| 0.22 | 0.013 | 0.22 | Falcipain 3 inhibitor | |||
| 0.206 | 0.004 | 0.206 | VLA-4 antagonist | |||
| 0.196 | 0.003 | 0.196 | Integrin alpha4beta7 antagonist | 0.028 0.01 CID_102066185 | ||
| 0.21 | 0.019 | 0.21 | GABA C receptor agonist | |||
| 0.327 | 0.137 | 0.327 | 5 Hydroxytryptamine release inhibitor | 0.282 0.186 CID_102066185 | ||
| 0.215 | 0.028 | 0.441 | Hemostatic | 0.441 0.005 CID_102066185 | CID_102066185 | |
| 0.231 | 0.047 | 0.231 | Insulin sensitizer | |||
| 0.314 | 0.131 | 0.314 | Analgesic | |||
| 0.282 | 0.103 | 0.41 | Vasodilator, coronary | 0.41 0.032 CID_102066185 | CID_102066185 | |
| 0.211 | 0.037 | 0.325 | Interferon gamma antagonist | 0.325 0.017 CID_102066185 | CID_102066185 | |
| 0.18 | 0.008 | 0.18 | Aminopeptidase I inhibitor | |||
| 0.191 | 0.025 | 0.191 | Cathepsin H inhibitor | |||
| 0.178 | 0.014 | 0.178 | Folate antagonist | 0.106 0.055 CID_102066185 | ||
| 0.234 | 0.072 | 0.234 | Neuropeptide Y2 antagonist | |||
| 0.178 | 0.017 | 0.178 | Papain-like protease (SARS coronavirus) inhibitor | 0.129 0.061 CID_102066185 | ||
| 0.245 | 0.091 | 0.245 | 5 Hydroxytryptamine release stimulant | 0.183 0.138 CID_102066185 | ||
| 0.245 | 0.093 | 0.364 | Spasmolytic | 0.364 0.048 CID_102066185 | CID_102066185 | |
| 0.158 | 0.009 | 0.158 | Vanilloid agonist | 0.121 0.018 CID_102066185 | ||
| 0.156 | 0.01 | 0.156 | Glutamate (mGluR7) agonist | |||
| 0.166 | 0.021 | 0.166 | Opioid antagonist | 0.093 0.053 CID_102066185 | ||
| 0.201 | 0.058 | 0.201 | Growth hormone agonist | |||
| 0.187 | 0.047 | 0.229 | Melanin inhibitor | 0.229 0.032 CID_102066185 | CID_102066185 | |
| 0.157 | 0.018 | 0.157 | DOPA decarboxylase inhibitor | |||
| 0.159 | 0.022 | 0.159 | Caspase 3 inhibitor | |||
| 0.204 | 0.067 | 0.386 | Non-steroidal antiinflammatory agent | 0.386 0.015 CID_102066185 | CID_102066185 | |
| 0.182 | 0.05 | 0.182 | Catenin beta inhibitor | |||
| 0.151 | 0.021 | 0.151 | Cathepsin G inhibitor | |||
| 0.158 | 0.028 | 0.158 | Mucolytic | 0.111 0.064 CID_102066185 | ||
| 0.132 | 0.003 | 0.132 | Glutamate (mGluR1) agonist | |||
| 0.229 | 0.103 | 0.229 | Transcription factor STAT inhibitor | |||
| 0.142 | 0.017 | 0.142 | Analgesic, opioid | 0.095 0.034 CID_102066185 | ||
| 0.15 | 0.026 | 0.15 | Catalase inhibitor | |||
| 0.156 | 0.033 | 0.24 | Expectorant | 0.24 0.014 CID_102066185 | CID_102066185 | |
| 0.135 | 0.012 | 0.135 | Carbonic anhydrase stimulant | |||
| 0.131 | 0.009 | 0.131 | Opioid agonist | 0.063 0.027 CID_102066185 | ||
| 0.129 | 0.011 | 0.129 | Endothelin-converting enzyme inhibitor | |||
| 0.159 | 0.042 | 0.159 | Protein-tyrosine phosphatase 1B inhibitor | 0.152 0.044 CID_102066185 | ||
| 0.175 | 0.059 | 0.175 | Protein-tyrosine phosphatase inhibitor | 0.154 0.074 CID_102066185 | ||
| 0.127 | 0.012 | 0.127 | NMDA receptor agonist | |||
| 0.135 | 0.021 | 0.135 | Opioid mu receptor antagonist | 0.07 0.046 CID_102066185 | ||
| 0.315 | 0.201 | 0.715 | Antiinflammatory | 0.715 0.028 CID_102066185 | CID_102066185 | |
| 0.122 | 0.009 | 0.122 | Erythropoietin receptor agonist | |||
| 0.117 | 0.003 | 0.117 | Integrin beta7 antagonist | |||
| 0.117 | 0.004 | 0.117 | Nociceptin (N/OFQ) receptor agonist | 0.024 0.012 CID_102066185 | ||
| 0.133 | 0.021 | 0.133 | Chymotrypsin inhibitor | |||
| 0.148 | 0.039 | 0.244 | Microtubule formation inhibitor | 0.244 0.01 CID_102066185 | CID_102066185 | |
| 0.111 | 0.004 | 0.111 | VCAM antagonist | 0.037 0.036 CID_102066185 | ||
| 0.159 | 0.052 | 0.159 | Bone formation stimulant | 0.14 0.067 CID_102066185 | ||
| 0.141 | 0.034 | 0.141 | Protease inhibitor | 0.11 0.056 CID_102066185 | ||
| 0.107 | 0.003 | 0.107 | Integrin alpha1beta1 antagonist | 0.047 0.009 CID_102066185 | ||
| 0.128 | 0.024 | 0.128 | Opioid delta receptor antagonist | |||
| 0.135 | 0.032 | 0.135 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.099 0.055 CID_102066185 | ||
| 0.141 | 0.038 | 0.141 | Nav1.4 sodium channel blocker | |||
| 0.111 | 0.009 | 0.111 | Phospholipase D inhibitor | |||
| 0.157 | 0.055 | 0.157 | Neuropeptide Y1 antagonist | |||
| 0.127 | 0.026 | 0.127 | ABCA1 expression enhancer | |||
| 0.104 | 0.004 | 0.104 | VCAM-1 antagonist | |||
| 0.124 | 0.025 | 0.124 | Glutamate receptor agonist | |||
| 0.101 | 0.004 | 0.101 | Integrin alpha4beta1 antagonist | |||
| 0.103 | 0.007 | 0.103 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.275 | 0.18 | 0.275 | Calcium channel L-type activator | |||
| 0.153 | 0.059 | 0.153 | Adenylate cyclase stimulant | |||
| 0.136 | 0.042 | 0.136 | TRPA1 agonist | |||
| 0.143 | 0.05 | 0.143 | Adenylate cyclase inhibitor | |||
| 0.097 | 0.004 | 0.097 | Membrane dipeptidase inhibitor | |||
| 0.171 | 0.079 | 0.171 | Lipocortins synthesis antagonist | 0.141 0.119 CID_102066185 | ||
| 0.134 | 0.043 | 0.134 | Photosensitizer | 0.134 0.043 CID_102066185 | ||
| 0.141 | 0.05 | 0.141 | Cholesterol synthesis inhibitor | 0.096 0.093 CID_102066185 | ||
| 0.103 | 0.013 | 0.103 | Opioid mu receptor agonist | 0.049 0.029 CID_102066185 | ||
| 0.114 | 0.025 | 0.114 | Bile acid receptor antagonist | |||
| 0.093 | 0.004 | 0.093 | Glutamate (mGluR1a) agonist | |||
| 0.122 | 0.034 | 0.122 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.106 | 0.019 | 0.106 | Glucagon-like peptide 1 agonist | |||
| 0.106 | 0.018 | 0.106 | Ribonucleoside-diphosphate reductase inhibitor | |||
| 0.091 | 0.005 | 0.091 | Glutamate (mGluR3) antagonist | |||
| 0.09 | 0.004 | 0.09 | Lysine carboxypeptidase inhibitor | |||
| 0.089 | 0.005 | 0.089 | Prostacyclin antagonist | |||
| 0.102 | 0.02 | 0.102 | Ribonucleotide reductase inhibitor | |||
| 0.101 | 0.02 | 0.101 | CC chemokine 5 receptor agonist | |||
| 0.1 | 0.02 | 0.1 | Cathepsin L inhibitor | |||
| 0.085 | 0.006 | 0.085 | AMPA 4 receptor antagonist | |||
| 0.085 | 0.006 | 0.085 | Integrin alpha5beta1 antagonist | |||
| 0.108 | 0.031 | 0.108 | Factor XII inhibitor | |||
| 0.157 | 0.08 | 0.157 | Arachidonic acid antagonist | |||
| 0.095 | 0.019 | 0.095 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.095 | 0.019 | 0.095 | GP IIb/IIIa receptor antagonist | |||
| 0.085 | 0.009 | 0.085 | HCV NS3/NS4A protease inhibitor | |||
| 0.087 | 0.011 | 0.087 | Angiotensin-converting enzyme inhibitor | 0.053 0.041 CID_102066185 | ||
| 0.077 | 0.003 | 0.077 | Integrin beta2 antagonist | |||
| 0.142 | 0.069 | 0.142 | Histone deacetylase SIRT1 inhibitor | |||
| 0.081 | 0.007 | 0.081 | Nociceptin (N/OFQ) receptor antagonist | |||
| 0.092 | 0.019 | 0.092 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.148 | 0.076 | 0.148 | Phospholipase A2 inhibitor | 0.131 0.099 CID_102066185 | ||
| 0.175 | 0.104 | 0.175 | Neurotrophic factor enhancer | 0.149 0.14 CID_102066185 | ||
| 0.076 | 0.004 | 0.076 | LFA antagonist | |||
| 0.103 | 0.032 | 0.103 | Opioid kappa receptor antagonist | |||
| 0.187 | 0.117 | 0.339 | Peptidyltransferase inhibitor | 0.339 0.014 CID_102066185 | CID_102066185 | |
| 0.087 | 0.018 | 0.087 | Glutamate (mGluR6) antagonist | |||
| 0.073 | 0.004 | 0.073 | Integrin alphaVbeta1 antagonist | |||
| 0.08 | 0.011 | 0.08 | Cathepsin L2 inhibitor | |||
| 0.096 | 0.028 | 0.096 | Phenylalanine 4-hydroxylase inhibitor | |||
| 0.096 | 0.028 | 0.096 | Matrix metalloproteinase inhibitor | |||
| 0.101 | 0.034 | 0.101 | Hematopoietic | |||
| 0.081 | 0.016 | 0.11 | Factor IXa inhibitor | 0.11 0.008 CID_102066185 | CID_102066185 | |
| 0.085 | 0.02 | 0.085 | Caspase 9 inhibitor | |||
| 0.069 | 0.005 | 0.069 | Kainate receptor agonist | |||
| 0.091 | 0.027 | 0.091 | Glycine receptor agonist | 0.066 0.064 CID_102066185 | ||
| 0.066 | 0.003 | 0.066 | ICAM 1 antagonist | |||
| 0.07 | 0.009 | 0.07 | Carbonic anhydrase I stimulant | |||
| 0.075 | 0.014 | 0.075 | Purinergic P2Y antagonist | 0.044 0.032 CID_102066185 | ||
| 0.071 | 0.009 | 0.071 | Factor XIa inhibitor | |||
| 0.074 | 0.013 | 0.074 | 5-Alpha-reductase inhibitor | |||
| 0.068 | 0.008 | 0.068 | Parathyroid hormone antagonist | 0.043 0.039 CID_102066185 | ||
| 0.094 | 0.034 | 0.094 | Histidine decarboxylase inhibitor | |||
| 0.062 | 0.004 | 0.062 | Glutamate (mGluR3) agonist | 0.032 0.022 CID_102066185 | ||
| 0.128 | 0.07 | 0.128 | Toll-Like receptor 2 antagonist | |||
| 0.139 | 0.08 | 0.139 | Heat shock protein 70 antagonist | |||
| 0.074 | 0.016 | 0.074 | Complement C3a chemotactic receptor antagonist | |||
| 0.071 | 0.014 | 0.071 | Carbonic anhydrase II stimulant | |||
| 0.077 | 0.021 | 0.077 | NMDA 2A receptor antagonist | |||
| 0.058 | 0.004 | 0.058 | Carboxypeptidase B inhibitor | |||
| 0.073 | 0.019 | 0.15 | Phosphorylase inhibitor | 0.15 0.007 CID_102066185 | CID_102066185 | |
| 0.156 | 0.103 | 0.361 | Hepatoprotectant | 0.361 0.017 CID_102066185 | CID_102066185 | |
| 0.069 | 0.016 | 0.069 | Prolyl endopeptidase inhibitor | |||
| 0.064 | 0.012 | 0.064 | Glutamate (mGluR4) antagonist | |||
| 0.127 | 0.076 | 0.261 | Amylase inhibitor | 0.261 0.025 CID_102066185 | CID_102066185 | |
| 0.071 | 0.02 | 0.071 | Glycine transporter 2 inhibitor | |||
| 0.088 | 0.039 | 0.088 | Metalloproteinase-9 inhibitor | |||
| 0.057 | 0.008 | 0.057 | Glucagon receptor antagonist | |||
| 0.09 | 0.041 | 0.09 | Estrogen-related receptor beta agonist | |||
| 0.085 | 0.037 | 0.085 | Epoxide hydrolase inhibitor | |||
| 0.075 | 0.027 | 0.075 | Argininosuccinate synthase inhibitor | |||
| 0.053 | 0.005 | 0.053 | Tryptophan 5 hydroxylase inhibitor | |||
| 0.065 | 0.018 | 0.065 | Lysophosphatidic acid 3 receptor antagonist | |||
| 0.132 | 0.084 | 0.24 | Cell wall synthesis inhibitor | 0.24 0.018 CID_102066185 | CID_102066185 | |
| 0.091 | 0.043 | 0.091 | Metalloproteinase-2 inhibitor | |||
| 0.091 | 0.044 | 0.091 | 3C-Like protease (SARS coronavirus) inhibitor | |||
| 0.06 | 0.014 | 0.06 | AICAR transformylase inhibitor | |||
| 0.066 | 0.02 | 0.066 | Plasminogen activator inhibitor antagonist | |||
| 0.1 | 0.055 | 0.1 | Falcipain inhibitor | 0.079 0.075 CID_102066185 | ||
| 0.1 | 0.055 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.063 | 0.019 | 0.063 | Immunoglobulin Fc receptor antagonist | |||
| 0.07 | 0.025 | 0.07 | Sphingosine 1-phosphate receptor 3 antagonist | |||
| 0.084 | 0.041 | 0.084 | Glutamate dehydrogenase inhibitor | |||
| 0.128 | 0.085 | 0.152 | Protein kinase stimulant | 0.152 0.067 CID_102066185 | CID_102066185 | |
| 0.064 | 0.022 | 0.064 | Bombesin 2 receptor antagonist | |||
| 0.096 | 0.054 | 0.096 | Falcipain 2 inhibitor | 0.076 0.075 CID_102066185 | ||
| 0.049 | 0.008 | 0.049 | Neutral endopeptidase inhibitor | |||
| 0.055 | 0.016 | 0.055 | Calcitonin receptor agonist | |||
| 0.062 | 0.023 | 0.062 | Neurotensin receptor antagonist | |||
| 0.042 | 0.004 | 0.042 | Integrin alphaLbeta2 antagonist | |||
| 0.067 | 0.03 | 0.067 | Cathepsin D inhibitor | |||
| 0.056 | 0.02 | 0.056 | Opioid kappa receptor agonist | 0.041 0.032 CID_102066185 | ||
| 0.076 | 0.04 | 0.076 | Elastase 1 inhibitor | |||
| 0.068 | 0.032 | 0.068 | Cathepsin E inhibitor | |||
| 0.08 | 0.044 | 0.08 | Glutamate decarboxylase inhibitor | |||
| 0.072 | 0.037 | 0.072 | Neutrophil collagenase inhibitor | |||
| 0.071 | 0.036 | 0.071 | MDM2 inhibitor | |||
| 0.065 | 0.031 | 0.065 | Cathepsin B inhibitor | |||
| 0.059 | 0.025 | 0.059 | Metalloproteinase-3 inhibitor | |||
| 0.059 | 0.027 | 0.059 | Dipeptidyl peptidase inhibitor | |||
| 0.051 | 0.019 | 0.051 | Glutamate (mGluR group III) antagonist | |||
| 0.104 | 0.072 | 0.104 | GABA C receptor antagonist | |||
| 0.062 | 0.031 | 0.062 | Matrix metalloproteinase (membrane-type) inhibitor | |||
| 0.045 | 0.015 | 0.045 | Integrin alpha2 antagonist | |||
| 0.185 | 0.156 | 0.185 | Transcription factor STAT3 inhibitor | |||
| 0.078 | 0.049 | 0.078 | GABA aminotransferase inhibitor | 0.074 0.055 CID_102066185 | ||
| 0.108 | 0.08 | 0.108 | Interleukin 8 antagonist | |||
| 0.046 | 0.017 | 0.046 | Aggrecanase 1 inhibitor | |||
| 0.042 | 0.014 | 0.042 | Glutamate (mGluR8) antagonist | |||
| 0.124 | 0.096 | 0.124 | Farnesoid X receptor antagonist | |||
| 0.076 | 0.048 | 0.076 | Vanilloid 4 agonist | |||
| 0.04 | 0.012 | 0.04 | Dipeptidyl peptidase I inhibitor | |||
| 0.036 | 0.008 | 0.036 | Thyroid hormone agonist | |||
| 0.056 | 0.029 | 0.056 | CC chemokine 5 receptor antagonist | |||
| 0.041 | 0.014 | 0.041 | Peptide deformylase inhibitor | |||
| 0.069 | 0.043 | 0.324 | Selectin antagonist | 0.324 0.005 CID_102066185 | CID_102066185 | |
| 0.034 | 0.01 | 0.034 | Baculoviral IAP repeat-containing protein 4 inhibitor | |||
| 0.072 | 0.047 | 0.072 | Peroxisome proliferator-activated receptor gamma agonist | |||
| 0.057 | 0.033 | 0.057 | Matrix metalloproteinase 1 inhibitor | |||
| 0.039 | 0.015 | 0.039 | Dipeptidyl peptidase II inhibitor | |||
| 0.034 | 0.011 | 0.034 | Purinergic P2Y12 antagonist | 0.021 0.018 CID_102066185 | ||
| 0.053 | 0.03 | 0.053 | Antimetabolite | 0.053 0.029 CID_102066185 | ||
| 0.082 | 0.059 | 0.082 | Inducible nitric-oxide synthase inhibitor | |||
| 0.039 | 0.017 | 0.039 | Factor XI inhibitor | |||
| 0.089 | 0.066 | 0.089 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.048 | 0.026 | 0.048 | Macrophage elastase inhibitor | |||
| 0.054 | 0.032 | 0.054 | Chemokine receptor agonist | |||
| 0.032 | 0.01 | 0.032 | Integrin alpha2beta1 antagonist | |||
| 0.06 | 0.039 | 0.06 | Plasminogen activator inhibitor | |||
| 0.046 | 0.025 | 0.046 | HIV-1 protease inhibitor | |||
| 0.134 | 0.113 | 0.384 | Nitric oxide antagonist | 0.384 0.027 CID_102066185 | CID_102066185 | |
| 0.041 | 0.021 | 0.041 | Glutamate (mGluR8) agonist | |||
| 0.053 | 0.033 | 0.053 | Aconitate hydratase inhibitor | |||
| 0.029 | 0.009 | 0.029 | Integrin alphaVbeta3 antagonist | |||
| 0.083 | 0.064 | 0.083 | Ornithine decarboxylase inhibitor | |||
| 0.127 | 0.108 | 0.127 | Pregnane X receptor agonist | |||
| 0.024 | 0.006 | 0.024 | Angiotensin-converting enzyme 2 inhibitor | |||
| 0.045 | 0.027 | 0.045 | Oxytocin agonist | |||
| 0.035 | 0.017 | 0.035 | AMPA 3 receptor antagonist | |||
| 0.143 | 0.125 | 0.143 | Succinate dehydrogenase inhibitor | |||
| 0.045 | 0.027 | 0.045 | Leukocyte elastase inhibitor | |||
| 0.059 | 0.042 | 0.059 | Bombesin 1 receptor agonist | |||
| 0.028 | 0.011 | 0.028 | Aminopeptidase P inhibitor | |||
| 0.068 | 0.052 | 0.068 | Secretase beta inhibitor | |||
| 0.058 | 0.041 | 0.058 | Aminopeptidase microsomal inhibitor | |||
| 0.021 | 0.005 | 0.021 | Tryptophan hydroxylase 1 inhibitor | |||
| 0.033 | 0.017 | 0.033 | Trypsin II inhibitor | |||
| 0.024 | 0.008 | 0.024 | Aminopeptidase A inhibitor | |||
| 0.02 | 0.004 | 0.02 | Carboxypeptidase B2 inhibitor | |||
| 0.022 | 0.007 | 0.022 | Nicotinic acid receptor 1 antagonist | |||
| 0.061 | 0.045 | 0.061 | Trypsin inhibitor | |||
| 0.065 | 0.051 | 0.065 | Sirtuin 1 inhibitor | |||
| 0.052 | 0.038 | 0.052 | Elastase inhibitor | |||
| 0.037 | 0.023 | 0.037 | Opioid delta receptor agonist | |||
| 0.02 | 0.006 | 0.02 | Carbonic anhydrase IV stimulant | |||
| 0.018 | 0.005 | 0.018 | Integrin alphaVbeta5 antagonist | |||
| 0.053 | 0.04 | 0.053 | DNA helicase inhibitor | |||
| 0.073 | 0.06 | 0.073 | Keratolytic | |||
| 0.082 | 0.069 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.025 | 0.012 | 0.025 | Vitronectin receptor antagonist | |||
| 0.042 | 0.029 | 0.042 | Cathepsin F inhibitor | |||
| 0.034 | 0.022 | 0.034 | HCV polyprotein inhibitor | |||
| 0.03 | 0.019 | 0.03 | Diacylglycerol O-acyltransferase 1 inhibitor | |||
| 0.027 | 0.016 | 0.037 | Toll-Like receptor 4 agonist | 0.037 0.006 CID_102066185 | CID_102066185 | |
| 0.036 | 0.024 | 0.036 | AMPA receptor agonist | |||
| 0.043 | 0.031 | 0.043 | Nicotinic receptor alpha3 subunit antagonist | |||
| 0.042 | 0.031 | 0.042 | Carbonic anhydrase IV inhibitor | |||
| 0.073 | 0.063 | 0.073 | Sphingosine 1-phosphate receptor antagonist | |||
| 0.098 | 0.087 | 0.098 | Calcium channel (voltage-sensitive) blocker | |||
| 0.052 | 0.041 | 0.052 | Human rhinovirus A protease inhibitor | |||
| 0.032 | 0.021 | 0.032 | HCV NS5B polymerase inhibitor | |||
| 0.017 | 0.007 | 0.017 | Integrin alphaVbeta6 antagonist | |||
| 0.035 | 0.026 | 0.035 | Kainate receptor 2 antagonist | |||
| 0.039 | 0.03 | 0.039 | Cholecystokinin antagonist | |||
| 0.035 | 0.027 | 0.035 | Histone deacetylase 7 inhibitor | |||
| 0.033 | 0.024 | 0.033 | Calpain 1 inhibitor | 0.031 0.029 CID_102066185 | ||
| 0.033 | 0.025 | 0.033 | RNA-directed RNA polymerase inhibitor | |||
| 0.059 | 0.051 | 0.059 | CDC25B inhibitor | |||
| 0.022 | 0.014 | 0.022 | Lysophosphatidic acid 1 receptor antagonist | |||
| 0.022 | 0.013 | 0.022 | Integrin beta5 antagonist | |||
| 0.081 | 0.073 | 0.106 | Triose-phosphate isomerase inhibitor | 0.106 0.042 CID_102066185 | CID_102066185 | |
| 0.041 | 0.033 | 0.041 | Histamine H2 receptor agonist | |||
| 0.029 | 0.021 | 0.029 | AMPA 1 receptor antagonist | |||
| 0.152 | 0.145 | 0.152 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.035 | 0.028 | 0.035 | Cholecystokinin A antagonist | |||
| 0.04 | 0.034 | 0.04 | Glutamate (mGluR group III) agonist | |||
| 0.073 | 0.067 | 0.073 | Viral attachment inhibitor | |||
| 0.019 | 0.014 | 0.019 | Integrin beta3 antagonist | |||
| 0.106 | 0.101 | 0.106 | Nav1.2 sodium channel blocker | |||
| 0.053 | 0.049 | 0.053 | Botulinum neurotoxin type A inhibitor | |||
| 0.095 | 0.091 | 0.161 | DNA polymerase I inhibitor | 0.161 0.043 CID_102066185 | CID_102066185 | |
| 0.033 | 0.029 | 0.033 | Growth factor receptor-bound protein 2 antagonist | |||
| 0.019 | 0.015 | 0.019 | Caspase 8 inhibitor | |||
| 0.016 | 0.013 | 0.016 | Thyroid hormone alpha agonist | |||
| 0.041 | 0.038 | 0.041 | Plasmin inhibitor | |||
| 0.035 | 0.032 | 0.035 | Cathepsin L1 inhibitor | |||
| 0.069 | 0.067 | 0.069 | Somatostatin 1 agonist | |||
| 0.033 | 0.031 | 0.036 | Ceramide glucosyltransferase inhibitor | 0.036 0.024 CID_102066185 | CID_102066185 | |
| 0.015 | 0.014 | 0.017 | Ileal bile acid transport inhibitor | 0.017 0.012 CID_102066185 | CID_102066185 | |
| 0.041 | 0.04 | 0.041 | Aminopeptidase N inhibitor | |||
| 0.015 | 0.016 | 0.016 | Vitamin D receptor agonist | 0.016 0.012 CID_102066185 | CID_102066185 | |
| 0.048 | 0.05 | 0.087 | Heparanase inhibitor | 0.087 0.005 CID_102066185 | CID_102066185 | |
| 0.02 | 0.023 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 CID_102066185 | CID_102066185 | |
| 0.022 | 0.026 | 0.035 | Vanilloid 2 agonist | 0.035 0.005 CID_102066185 | CID_102066185 | |
| 0.053 | 0.057 | 0.065 | Lipocortins synthesis agonist | 0.065 0.027 CID_102066185 | CID_102066185 | |
| 0.199 | 0.203 | 0.223 | Histamine release inhibitor | 0.223 0.178 CID_102066185 | CID_102066185 | |
| 0.167 | 0.172 | 0.236 | DNA synthesis inhibitor | 0.236 0.077 CID_102066185 | CID_102066185 | |
| 0.148 | 0.161 | 0.287 | Vasodilator | 0.287 0.053 CID_102066185 | CID_102066185 | |
| 0.138 | 0.162 | 0.446 | Free radical scavenger | 0.446 0.022 CID_102066185 | CID_102066185 | |
| 0.084 | 0.112 | 0.205 | Alkylator | 0.205 0.025 CID_102066185 | CID_102066185 | |
| 0.04 | 0.069 | 0.062 | Alpha-mannosidase inhibitor | 0.062 0.024 CID_102066185 | CID_102066185 | |
| 0.125 | 0.154 | 0.185 | ATPase inhibitor | 0.185 0.051 CID_102066185 | CID_102066185 | |
| 0.047 | 0.076 | 0.072 | Nitric oxide donor | 0.072 0.03 CID_102066185 | CID_102066185 | |
| 0.046 | 0.076 | 0.07 | Phosphofructokinase-1 inhibitor | 0.07 0.048 CID_102066185 | CID_102066185 | |
| 0.069 | 0.099 | 0.2 | Monophenol monooxygenase inhibitor | 0.2 0.033 CID_102066185 | CID_102066185 | |
| 0.033 | 0.063 | 0.055 | Microtubule stabilization | 0.055 0.022 CID_102066185 | CID_102066185 | |
| 0.035 | 0.065 | 0.09 | Protein 50S ribosomal subunit inhibitor | 0.09 0.016 CID_102066185 | CID_102066185 | |
| 0.123 | 0.161 | 0.132 | Ca2+-transporting ATPase inhibitor | 0.132 0.111 CID_102066185 | CID_102066185 | |
| 0.139 | 0.18 | 0.499 | Antioxidant | 0.499 0.02 CID_102066185 | CID_102066185 | |
| 0.058 | 0.105 | 0.073 | Glycine receptor antagonist | 0.073 0.07 CID_102066185 | CID_102066185 | |
| 0.067 | 0.117 | 0.095 | ATPase (Vacuolar H+) inhibitor | 0.095 0.046 CID_102066185 | CID_102066185 | |
| 0.076 | 0.127 | 0.152 | Toll-Like receptor 4 antagonist | 0.152 0.02 CID_102066185 | CID_102066185 | |
| 0.026 | 0.079 | 0.052 | Mannosidase inhibitor | 0.052 0.023 CID_102066185 | CID_102066185 | |
| 0.041 | 0.11 | 0.092 | Na+ K+ transporting ATPase inhibitor | 0.092 0.039 CID_102066185 | CID_102066185 | |
| 0.025 | 0.1 | 0.056 | Neuraminidase (Influenza A) inhibitor | 0.056 0.016 CID_102066185 | CID_102066185 | |
| 0.18 | 0.256 | 0.599 | Antibacterial | 0.599 0.019 CID_102066185 | CID_102066185 | |
| 0.031 | 0.114 | 0.047 | Cytokine production stimulant | 0.047 0.037 CID_102066185 | CID_102066185 | |
| 0.215 | 0.298 | 0.357 | Caspase 9 stimulant | 0.357 0.14 CID_102066185 | CID_102066185 | |
| 0.059 | 0.152 | 0.114 | Transcription factor NF kappa B stimulant | 0.114 0.028 CID_102066185 | CID_102066185 | |
| 0.03 | 0.127 | 0.164 | Antineoplastic antibiotic | 0.164 0.028 CID_102066185 | CID_102066185 | |
| 0.009 | 0.108 | 0.023 | Antibiotic Anthracycline-like | 0.023 0.006 CID_102066185 | CID_102066185 | |
| 0.105 | 0.208 | 0.238 | Antiamyloidogenic | 0.238 0.077 CID_102066185 | CID_102066185 | |
| 0.066 | 0.185 | 0.227 | Lipid peroxidase inhibitor | 0.227 0.032 CID_102066185 | CID_102066185 | |
| 0.01 | 0.137 | 0.034 | Sodium/glucose cotransporter inhibitor | 0.034 0.009 CID_102066185 | CID_102066185 | |
| 0.036 | 0.172 | 0.07 | Adenine nucleotide translocase inhibitor | 0.07 0.015 CID_102066185 | CID_102066185 | |
| 0.051 | 0.197 | 0.093 | NADH dehydrogenase inhibitor | 0.093 0.052 CID_102066185 | CID_102066185 | |
| 0.018 | 0.165 | 0.063 | Neuraminidase inhibitor | 0.063 0.04 CID_102066185 | CID_102066185 | |
| 0.046 | 0.198 | 0.143 | UDP-glucose 4-epimerase inhibitor | 0.143 0.031 CID_102066185 | CID_102066185 | |
| 0.024 | 0.198 | 0.071 | Neuraminidase (influenza) inhibitor | 0.071 0.034 CID_102066185 | CID_102066185 | |
| 0.1 | 0.28 | 0.203 | DNA damaging | 0.203 0.113 CID_102066185 | CID_102066185 | |
| 0.006 | 0.202 | 0.027 | Sodium/glucose cotransporter 2 inhibitor | 0.027 0.017 CID_102066185 | CID_102066185 | |
| 0.017 | 0.227 | 0.057 | Antibiotic Aminoglycoside-like | 0.057 0.01 CID_102066185 | CID_102066185 | |
| 0.146 | 0.366 | 0.545 | Apoptosis agonist | 0.545 0.062 CID_102066185 | CID_102066185 | |
| 0.021 | 0.252 | 0.083 | Glucose-6-phosphate translocase inhibitor | 0.083 0.01 CID_102066185 | CID_102066185 | |
| 0.067 | 0.3 | 0.182 | NOS3 expression enhancer | 0.182 0.049 CID_102066185 | CID_102066185 | |
| 0.007 | 0.276 | 0.025 | Protein 30S ribosomal subunit inhibitor | 0.025 0.015 CID_102066185 | CID_102066185 | |
| 0.062 | 0.356 | 0.337 | Tumour necrosis factor alpha release inhibitor | 0.337 0.041 CID_102066185 | CID_102066185 | |
| 0.025 | 0.42 | 0.1 | Multidrug resistance-associated protein 1 inhibitor | 0.1 0.078 CID_102066185 | CID_102066185 | |
| 0.014 | 0.483 | 0.155 | Topoisomerase I inhibitor | 0.155 0.039 CID_102066185 | CID_102066185 | |
| 0.072 | 0.65 | 0.123 | CC chemokine 6 receptor antagonist | 0.123 0.102 CID_102066185 | CID_102066185 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |